BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

789 related articles for article (PubMed ID: 12027420)

  • 21. ANCA-associated vasculitis: diagnostic and therapeutic strategy.
    Ozaki S
    Allergol Int; 2007 Jun; 56(2):87-96. PubMed ID: 17460438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Autoantibodies associated with vasculitis].
    Aotsuka S
    Nihon Rinsho; 1994 Aug; 52(8):2029-33. PubMed ID: 7933581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis.
    Kallenberg CG
    Curr Opin Rheumatol; 2007 Jan; 19(1):17-24. PubMed ID: 17143091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antineutrophilic cytoplasmic antibodies (ANCA) in inflammatory rheumatic diseases: immunodiagnostic and immunopathogenetic aspects].
    Csernok E; Gross WL
    Z Rheumatol; 1995; 54(1):26-38. PubMed ID: 7725808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antineutrophil cytoplasmic antibodies reacting with the pro form of proteinase 3 and disease activity in patients with Wegener's granulomatosis and microscopic polyangiitis.
    Russell KA; Fass DN; Specks U
    Arthritis Rheum; 2001 Feb; 44(2):463-8. PubMed ID: 11229478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone marrow-derived cells are sufficient and necessary targets to mediate glomerulonephritis and vasculitis induced by anti-myeloperoxidase antibodies.
    Schreiber A; Xiao H; Falk RJ; Jennette JC
    J Am Soc Nephrol; 2006 Dec; 17(12):3355-64. PubMed ID: 17108314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [ANCA-associated forms of vasculitis].
    Helmchen U; Kneissler U; Prall F
    Verh Dtsch Ges Pathol; 1996; 80():38-45. PubMed ID: 9065053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [ANCA-associated vasculitis (Wegener's granulomatosis, Churg-Strauss syndrome, microscopic polyangiitis). 1. Systemic aspects, pathogenesis and clinical aspects].
    Gross WL; Reinhold-Keller E
    Z Rheumatol; 1995; 54(5):279-90. PubMed ID: 8578884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ANCA-associated vasculitis with renal involvement: an outcome analysis.
    Weidner S; Geuss S; Hafezi-Rachti S; Wonka A; Rupprecht HD
    Nephrol Dial Transplant; 2004 Jun; 19(6):1403-11. PubMed ID: 15069175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-neutrophil cytoplasmic antibodies engage and activate human neutrophils via Fc gamma RIIa.
    Porges AJ; Redecha PB; Kimberly WT; Csernok E; Gross WL; Kimberly RP
    J Immunol; 1994 Aug; 153(3):1271-80. PubMed ID: 8027554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antineutrophil cytoplasmic autoantibodies in systemic vasculitis].
    Hagemo JS; Aasarød K; Moen T
    Tidsskr Nor Laegeforen; 2002 May; 122(12):1185-8. PubMed ID: 12089844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What do antineutrophil cytoplasmic antibodies (ANCA) tell us?
    Savige J; Pollock W; Trevisin M
    Best Pract Res Clin Rheumatol; 2005 Apr; 19(2):263-76. PubMed ID: 15857795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antineutrophil cytoplasmic antibodies induce human monocytes to produce oxygen radicals in vitro.
    Weidner S; Neupert W; Goppelt-Struebe M; Rupprecht HD
    Arthritis Rheum; 2001 Jul; 44(7):1698-706. PubMed ID: 11465722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of anti-neutrophil cytoplasmic antibodies in small vessel vasculitis: Comparative analysis of different strategies.
    Vermeersch P; Vervaeke S; Blockmans D; van Hoovels L; Mariën G; Vanmaele H; Bossuyt X
    Clin Chim Acta; 2008 Nov; 397(1-2):77-81. PubMed ID: 18708041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contribution of myeloperoxidase in vasculitis development.
    Suzuki K; Okazaki T
    Jpn J Infect Dis; 2004 Oct; 57(5):S2-3. PubMed ID: 15507759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ANCA glomerulonephritis and vasculitis: a Chapel Hill perspective.
    Falk RJ; Nachman PH; Hogan SL; Jennette JC
    Semin Nephrol; 2000 May; 20(3):233-43. PubMed ID: 10855933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An index for renal outcome in ANCA-associated glomerulonephritis.
    Vergunst CE; van Gurp E; Hagen EC; van Houwelingen HC; Hauer HA; Noël LH; Waldherr R; Ferrario F; van der Woude FJ; Bruijn JA; Bajema IM;
    Am J Kidney Dis; 2003 Mar; 41(3):532-8. PubMed ID: 12612975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathophysiology of ANCA-associated vasculitides: are ANCA really pathogenic?
    Tervaert JW; Heeringa P
    Neth J Med; 2003 Dec; 61(12):404-7. PubMed ID: 15025415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA genes in ANCA-associated vasculitides.
    Griffith ME; Pusey CD
    Exp Clin Immunogenet; 1997; 14(3):196-205. PubMed ID: 9493788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C-antineutrophil cytoplasmic antibody positivity in vasculitis patients is associated with the Z allele of alpha-1-antitrypsin, and P-antineutrophil cytoplasmic antibody positivity with the S allele.
    Griffith ME; Lovegrove JU; Gaskin G; Whitehouse DB; Pusey CD
    Nephrol Dial Transplant; 1996 Mar; 11(3):438-43. PubMed ID: 8671812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.